The Impact of Smoking on Clinical Outcomes after Percutaneous Coronary Intervention in Women Compared to Men

Table 1

Baseline characteristics of 1799 participants stratified by smoking status.

	Smoker (n = 847)	Nonsmoker (n = 952)		OR	95% CI for OR
					Lower	Upper
Age (months)	57.95 ± 11.37	60.08 ± 10.70	<0.001	0.976	0.967	0.985	<0.001
Gender (male)	634 (74.9%)	467 (49.1%)	<0.001	2.586	2.088	3.204	<0.001
DM	231 (27.3%)	302 (31.7%)	0.039	0.988	0.786	1.243	0.918
HTN	385 (45.5%)	614 (64.5%)	<0.001	0.643	0.521	0.794	<0.001
HLP	398 (47.0%)	519 (54.5%)	0.001	1.015	0.818	1.258	0.894
MACE	80 (9.4%)	50 (5.3%)	0.001	1.878	1.276	2.764	0.001
Time-to-event (months)	50.79 ± 45.33	52.56 ± 44.37	0.828	—	—	—	—

DM: diabetes mellitus, HTN: hypertension, HLP: hyperlipidemia, MACE: major adverse cardiac events, n: number, : extracted from t-test or chi-square test in univariate approach, OR: odds ratio (adjusted), CI: confidence interval, and : extracted from multiple logistic regression analysis. Bold values imply significant differences.